Beta cell function in type 1 diabetes determined from clinical and fasting biochemical variables

Diabetologia
John M WentworthImmune Tolerance Network Study Group

Abstract

Beta cell function in type 1 diabetes is commonly assessed as the average plasma C-peptide concentration over 2 h following a mixed-meal test (CPAVE). Monitoring of disease progression and response to disease-modifying therapy would benefit from a simpler, more convenient and less costly measure. Therefore, we determined whether CPAVE could be reliably estimated from routine clinical variables. Clinical and fasting biochemical data from eight randomised therapy trials involving participants with recently diagnosed type 1 diabetes were used to develop and validate linear models to estimate CPAVE and to test their accuracy in estimating loss of beta cell function and response to immune therapy. A model based on disease duration, BMI, insulin dose, HbA1c, fasting plasma C-peptide and fasting plasma glucose most accurately estimated loss of beta cell function (area under the receiver operating characteristic curve [AUROC] 0.89 [95% CI 0.87, 0.92]) and was superior to the commonly used insulin-dose-adjusted HbA1c (IDAA1c) measure (AUROC 0.72 [95% CI 0.68, 0.76]). Model-estimated CPAVE (CPEST) reliably identified treatment effects in randomised trials. CPEST, compared with CPAVE, required only a modest (up to 17%) increase in sample ...Continue Reading

References

Mar 1, 1995·Diabetic Medicine : a Journal of the British Diabetic Association·E MobergU Adamson
Nov 15, 2007·Diabetes Care·Jay M SosenkoUNKNOWN Diabetes Prevention Trial-Type 1 Study Group
May 14, 2009·Diabetes Care·Henrik B MortensenUNKNOWN Hvidoere Study Group on Childhood Diabetes
Nov 27, 2009·The New England Journal of Medicine·Mark D PescovitzUNKNOWN Type 1 Diabetes TrialNet Anti-CD20 Study Group
Jan 14, 2010·Diabetes Care·Peter A GottliebUNKNOWN Type 1 Diabetes TrialNet MMF/DZB Study Group
Apr 27, 2012·The New England Journal of Medicine·John C Pickup
Sep 22, 2012·The Journal of Clinical Endocrinology and Metabolism·Roy W BeckUNKNOWN T1D Exchange Clinic Network
Dec 13, 2012·Diabetic Medicine : a Journal of the British Diabetic Association·J S Skyler
Sep 26, 2015·Diabetes Care·Diane K WherrettUNKNOWN Type 1 Diabetes TrialNet Study Group
Nov 5, 2016·Diabetes/metabolism Research and Reviews·Brian N BundyUNKNOWN Type 1 Diabetes TrialNet Study Group

❮ Previous
Next ❯

Citations

Nov 6, 2018·Diabetologia·Flemming Pociot
Jun 12, 2020·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Bas S UitbeijerseEelco J P de Koning
Jan 27, 2020·Diabetologia·John M WentworthLeonard C Harrison

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.